US Stock MarketDetailed Quotes

APRE Aprea Therapeutics

Watchlist

2.980
+0.010+0.34%

Close Nov 27 16:00 ET

2.980
0.0000.00%

Post 16:00 ET

16.20MMarket Cap-1064P/E (TTM)

Aprea Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

3.53%26.25M

3.65%28.69M

4.43%32.37M

-24.94%21.61M

-23.43%25.35M

-29.13%27.69M

-34.95%31M

-45.76%28.79M

-Cash and cash equivalents

3.53%26.25M

3.65%28.69M

4.43%32.37M

-24.94%21.61M

-23.43%25.35M

-29.13%27.69M

-34.95%31M

-45.76%28.79M

Other current assets

-18.19%234.2K

-9.29%865.09K

-31.67%698.86K

-33.11%914.28K

-20.74%286.26K

-31.92%953.67K

-57.26%1.02M

-61.04%1.37M

Total current assets

3.29%26.48M

3.22%29.56M

3.28%33.07M

-25.31%22.52M

-23.40%25.64M

-29.22%28.64M

-36.02%32.02M

-46.71%30.15M

Non current assets

Net PPE

0.87%86.95K

5,375.93%92.38K

4,616.68%90.18K

3,707.07%88.36K

-27.43%86.2K

-99.12%1.69K

-99.27%1.91K

-98.89%2.32K

-Gross PPE

--86.95K

----

205.09%138.48K

----

-86.11%45.39K

-Accumulated depreciation

----

-16.37%-50.12K

----

63.19%-43.07K

Other non current assets

699.03%323.2K

677.56%312.42K

--40.99K

--40.72K

37.81%40.45K

36.86%40.18K

----

Total non current assets

223.85%410.15K

866.87%404.8K

6,760.30%131.17K

5,461.35%129.08K

-14.50%126.65K

-81.02%41.87K

-99.35%1.91K

-99.03%2.32K

Total assets

4.38%26.89M

4.48%29.96M

3.68%33.2M

-24.89%22.65M

-23.36%25.77M

-29.50%28.68M

-36.39%32.02M

-46.93%30.16M

Liabilities

Current liabilities

Payables

33.78%1.15M

-14.75%964.33K

59.61%1.32M

98.20%1.67M

-24.08%862.55K

-71.65%1.13M

-58.45%826.03K

-52.47%842.75K

-accounts payable

33.78%1.15M

-14.75%964.33K

59.61%1.32M

98.20%1.67M

-24.08%862.55K

-71.65%1.13M

-58.45%826.03K

-52.47%842.75K

Current accrued expenses

-20.07%1.81M

-3.07%1.5M

-27.48%1.21M

21.76%1.17M

91.89%2.26M

-15.41%1.54M

-57.49%1.67M

-75.59%960.36K

Current deferred liabilities

--0

--50.74K

--148.41K

--528.97K

----

--0

Current liabilities

-12.73%3.64M

-21.68%3.09M

-29.86%2.97M

37.00%4.39M

4.20%4.17M

-48.59%3.95M

-37.09%4.23M

-56.25%3.2M

Non current liabilities

Preferred securities outside stock equity

0.00%1.31M

-56.28%1.31M

-98.09%1.31M

--1.31M

Total non current liabilities

0.00%1.31M

-56.28%1.31M

-98.09%1.31M

4,572.19%1.31M

--1.31M

Total liabilities

-9.68%4.95M

-16.28%4.41M

-22.79%4.28M

26.25%5.7M

-21.72%5.48M

-93.12%5.26M

-17.93%5.54M

-38.33%4.51M

Shareholders'equity

Share capital

45.48%5.44K

45.54%5.43K

40.72%3.74K

-92.85%3.74K

-84.06%3.73K

-83.02%3.73K

143.13%2.66K

-common stock

45.48%5.44K

45.54%5.43K

40.72%3.74K

-92.85%3.74K

-84.06%3.73K

-83.02%3.73K

143.13%2.66K

Retained earnings

-4.43%-318.15M

-4.29%-314.36M

-4.26%-310.89M

-4.86%-308.08M

-4.56%-304.64M

-4.91%-301.44M

-57.71%-298.18M

-62.20%-293.8M

Paid-in capital

4.51%350.69M

4.49%350.55M

4.54%350.44M

1.69%335.64M

2.25%335.56M

28.15%335.49M

37.91%335.22M

36.96%330.06M

Gains losses not affecting retained earnings

0.29%-10.6M

0.06%-10.63M

-0.61%-10.63M

0.11%-10.61M

-3.86%-10.64M

-3.59%-10.63M

-1.31%-10.56M

-2.55%-10.62M

Total stockholders'equity

8.17%21.95M

9.14%25.56M

9.22%28.92M

-33.89%16.95M

-23.80%20.29M

165.46%23.42M

-39.25%26.48M

-48.20%25.64M

Total equity

8.17%21.95M

9.14%25.56M

9.22%28.92M

-33.89%16.95M

-23.80%20.29M

165.46%23.42M

-39.25%26.48M

-48.20%25.64M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	3.53%26.25M	3.65%28.69M	4.43%32.37M	-24.94%21.61M	-24.94%21.61M	-23.43%25.35M	-29.13%27.69M	-34.95%31M	-45.76%28.79M	-45.76%28.79M
-Cash and cash equivalents	3.53%26.25M	3.65%28.69M	4.43%32.37M	-24.94%21.61M	-24.94%21.61M	-23.43%25.35M	-29.13%27.69M	-34.95%31M	-45.76%28.79M	-45.76%28.79M
Other current assets	-18.19%234.2K	-9.29%865.09K	-31.67%698.86K	-33.11%914.28K	-33.11%914.28K	-20.74%286.26K	-31.92%953.67K	-57.26%1.02M	-61.04%1.37M	-61.04%1.37M
Total current assets	3.29%26.48M	3.22%29.56M	3.28%33.07M	-25.31%22.52M	-25.31%22.52M	-23.40%25.64M	-29.22%28.64M	-36.02%32.02M	-46.71%30.15M	-46.71%30.15M
Non current assets
Net PPE	0.87%86.95K	5,375.93%92.38K	4,616.68%90.18K	3,707.07%88.36K	3,707.07%88.36K	-27.43%86.2K	-99.12%1.69K	-99.27%1.91K	-98.89%2.32K	-98.89%2.32K
-Gross PPE	--86.95K	----	----	205.09%138.48K	205.09%138.48K	----	----	----	-86.11%45.39K	-86.11%45.39K
-Accumulated depreciation	----	----	----	-16.37%-50.12K	-16.37%-50.12K	----	----	----	63.19%-43.07K	63.19%-43.07K
Other non current assets	699.03%323.2K	677.56%312.42K	--40.99K	--40.72K	--40.72K	37.81%40.45K	36.86%40.18K	----	----	----
Total non current assets	223.85%410.15K	866.87%404.8K	6,760.30%131.17K	5,461.35%129.08K	5,461.35%129.08K	-14.50%126.65K	-81.02%41.87K	-99.35%1.91K	-99.03%2.32K	-99.03%2.32K
Total assets	4.38%26.89M	4.48%29.96M	3.68%33.2M	-24.89%22.65M	-24.89%22.65M	-23.36%25.77M	-29.50%28.68M	-36.39%32.02M	-46.93%30.16M	-46.93%30.16M
Liabilities
Current liabilities
Payables	33.78%1.15M	-14.75%964.33K	59.61%1.32M	98.20%1.67M	98.20%1.67M	-24.08%862.55K	-71.65%1.13M	-58.45%826.03K	-52.47%842.75K	-52.47%842.75K
-accounts payable	33.78%1.15M	-14.75%964.33K	59.61%1.32M	98.20%1.67M	98.20%1.67M	-24.08%862.55K	-71.65%1.13M	-58.45%826.03K	-52.47%842.75K	-52.47%842.75K
Current accrued expenses	-20.07%1.81M	-3.07%1.5M	-27.48%1.21M	21.76%1.17M	21.76%1.17M	91.89%2.26M	-15.41%1.54M	-57.49%1.67M	-75.59%960.36K	-75.59%960.36K
Current deferred liabilities	--0	--50.74K	--148.41K	--528.97K	--528.97K	----	----	----	--0	--0
Current liabilities	-12.73%3.64M	-21.68%3.09M	-29.86%2.97M	37.00%4.39M	37.00%4.39M	4.20%4.17M	-48.59%3.95M	-37.09%4.23M	-56.25%3.2M	-56.25%3.2M
Non current liabilities
Preferred securities outside stock equity	0.00%1.31M	0.00%1.31M	0.00%1.31M	0.00%1.31M	0.00%1.31M	-56.28%1.31M	-98.09%1.31M	--1.31M	--1.31M	--1.31M
Total non current liabilities	0.00%1.31M	0.00%1.31M	0.00%1.31M	0.00%1.31M	0.00%1.31M	-56.28%1.31M	-98.09%1.31M	4,572.19%1.31M	--1.31M	--1.31M
Total liabilities	-9.68%4.95M	-16.28%4.41M	-22.79%4.28M	26.25%5.7M	26.25%5.7M	-21.72%5.48M	-93.12%5.26M	-17.93%5.54M	-38.33%4.51M	-38.33%4.51M
Shareholders'equity
Share capital	45.48%5.44K	45.54%5.43K	45.54%5.43K	40.72%3.74K	40.72%3.74K	-92.85%3.74K	-84.06%3.73K	-83.02%3.73K	143.13%2.66K	143.13%2.66K
-common stock	45.48%5.44K	45.54%5.43K	45.54%5.43K	40.72%3.74K	40.72%3.74K	-92.85%3.74K	-84.06%3.73K	-83.02%3.73K	143.13%2.66K	143.13%2.66K
Retained earnings	-4.43%-318.15M	-4.29%-314.36M	-4.26%-310.89M	-4.86%-308.08M	-4.86%-308.08M	-4.56%-304.64M	-4.91%-301.44M	-57.71%-298.18M	-62.20%-293.8M	-62.20%-293.8M
Paid-in capital	4.51%350.69M	4.49%350.55M	4.54%350.44M	1.69%335.64M	1.69%335.64M	2.25%335.56M	28.15%335.49M	37.91%335.22M	36.96%330.06M	36.96%330.06M
Gains losses not affecting retained earnings	0.29%-10.6M	0.06%-10.63M	-0.61%-10.63M	0.11%-10.61M	0.11%-10.61M	-3.86%-10.64M	-3.59%-10.63M	-1.31%-10.56M	-2.55%-10.62M	-2.55%-10.62M
Total stockholders'equity	8.17%21.95M	9.14%25.56M	9.22%28.92M	-33.89%16.95M	-33.89%16.95M	-23.80%20.29M	165.46%23.42M	-39.25%26.48M	-48.20%25.64M	-48.20%25.64M
Total equity	8.17%21.95M	9.14%25.56M	9.22%28.92M	-33.89%16.95M	-33.89%16.95M	-23.80%20.29M	165.46%23.42M	-39.25%26.48M	-48.20%25.64M	-48.20%25.64M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data